VRCA compared with SHIM: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

SHIMShimmick Corp

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

SHIMShimmick Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

VRCA, solidSHIM, dashed

Supply-chain overlap

Revenue flow

VRCA: latest quarter is a loss; flow not drawable. SHIM: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Shared 0

No disclosed counterparties: SHIM.

Only SHIM 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

VRCAVerrica Pharmaceuticals Inc.

3.30▼−3.51%· post 3.40

Mkt cap$57.5MRevenue$6MQ2 FY26Revenue$36MFY25

SHIMShimmick Corp

2.54▼−1.17%· post 2.54

ClosedOct 30 '26

Mkt cap$103.8MRevenue$142MQ3 FY26Revenue$633MFY23

Compare

ClosedOct 30 '26

VRCAVerrica Pharmaceuticals Inc.

SHIMShimmick Corp

3.30▼−3.51%post 3.40

Price

2.54▼−1.17%post 2.54

$57.5M

Mkt cap

$103.8M

Q2 FY26$6M

Revenue

$142MQ3 FY26

FY25$36M

Revenue

$633MFY23

VRCA3.30▼−3.51%vsSHIM2.54▼−1.17%ClosedOct 30 '26